Chief Executive Officer
Dr. Peter Payne has established and run a variety of companies – from the early days of electronic publishing, to medical devices successfully marketed in Canada, the USA, Europe and Asia. He has been involved with government organizations, private and public companies, reverse take-overs, venture capital corporations and not-for-profit groups. Dr. Payne earned a Ph.D. (Pathology) from the University of British Columbia, and was a Clinical Instructor and Honorary Lecturer at UBC’s Faculty of Medicine. He is currently Adjunct Professor, Beedie School of Business and Co-Associate Director of SFU Venture Connection. Dr. Payne is also a mentor in entrepreneurship programs for Genome and Life Sciences companies, and a mentor for the SFU Beedie School of Business. He has been an invited speaker at international conferences, holds a number of patents and has received several awards for his work. He is also the past Director of Programs at the BC Technology Industry Association, and Executive-in-Residence for health technologies. Dr. Payne frequently speaks about the parallels between science and entrepreneurship. He explains the benefits of applying the scientific method to business concepts plus the social and economic impact of technology on Canada.

Director, Business Development & Strategic Initiatives
Dr. Samudra Dissanayake is a results-driven Life Science management professional who has worked both in health science and innovation in her previous roles at the National Institutes of Health, USA and the University of BC (UBC). She is widely recognized for her ability to create, develop and manage partnerships with key stakeholders in academia, hospitals, government and industry, to facilitate the advancement and commercialization of innovative medical technologies. During her tenure at UBC, Dr. Dissanayake managed a multi-million dollar federal grant which supported university – industry research for a large BC-wide preclinical network that generated approximately $2.5M revenue/year. She continues to attract significant industry partners and funding to Innovation Boulevard to support the Health Tech Innovation Foundation (HTIF) and associated industry partners. Dr. Dissanayake holds Ph.D. and M.Sc. degrees from the University of Maryland and Illinois State University USA and has certifications in Technology Transfer from the US National Institutes of Health. She is a previous Fulbright scholar and has received numerous awards for her contributions to cancer research including the American Association for Cancer Research Aflac award.

Director of Programs
Dr. Malcolm Kennard has over 25 years of experience working in the innovation and commercialization space in North America both in biotech and Life Science industries. His experience has ranged from engineering and manufacturing to the health care industry, drug and device development working for large companies such as Pfizer and BioMarin to smaller start-up companies such as Chromos Molecular Systems Inc., Synapse Technologies Inc, Protox and viDA Therapeutics Inc. etc. His unique experience bridging academia and industry enables a focus on the promotion of company technology and facilitating funding and research, as well as the business development and commercialization skills around such key technologies.

Program Coordinator
Betty Ly has a passion for innovative science and technology. She is the primary contact for information about the Innovation Boulevard Health Tech Accelerator. With the unique combination of her science background and 5+ years of event management experience, Betty brings her experience and expertise into Innovation Boulevard and hopes to enhance community engagement while pushing the boundaries of health technology.